SI9520094B - N-substituirani 3-azabiciklo/3.2.0/ heptanski derivati uporabni kot nevroleptiki - Google Patents

N-substituirani 3-azabiciklo/3.2.0/ heptanski derivati uporabni kot nevroleptiki Download PDF

Info

Publication number
SI9520094B
SI9520094B SI9520094A SI9520094A SI9520094B SI 9520094 B SI9520094 B SI 9520094B SI 9520094 A SI9520094 A SI 9520094A SI 9520094 A SI9520094 A SI 9520094A SI 9520094 B SI9520094 B SI 9520094B
Authority
SI
Slovenia
Prior art keywords
formula
azabicyclo
group
hydroxyl
amino
Prior art date
Application number
SI9520094A
Other languages
English (en)
Other versions
SI9520094A (en
Inventor
Gerd Steiner
Rainer Munschauer
Thomas Hoeger
Liliane Unger
Hans-Juergen Teschendorf
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of SI9520094A publication Critical patent/SI9520094A/sl
Publication of SI9520094B publication Critical patent/SI9520094B/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (3)

1 Patentni zahtevki 1. N-substituiran 3-azabiciklo[3.2.0]heptanski derivat s formulo I
N—(CH2)2. R2,
Ά kjer je R1 nafitil, ki je mono- ali disubstituiran z atomi halogenov, je R2 vodik, hidroksil, Ci-C4-alkil ali Ci-C4-alkoksi ali je skupaj s sosednjim ogljikovim atomom C=0 ali C=S, sta X in Y ogljikova atoma, CH, CH2, NH ali Ci-C4-alkil-N skupine ali dušikova atoma, je Z CO je A vodik, hidroksil, amino, merkapto, Ci-C4-alkilamino, di-CrC4- alkilamino, Ci-C4-alkiltio ali CrC4-alkoksi, ali je skupaj s sosednjim ogljikovim atomom C=0, ali je A C3-C4-alkilenska skupina, ki je vezana na Y in lahko vsebuje eno ali dve ne-kumulativni dvojni vezi in v kateri je lahko ena CH ali CH2 skupina nadomeščena z dušikovim ali žveplovim atomom ali NH ah N-CH3 skupino, in kjer je lahko obroč monosubstituiran bodisi s fluorovim ali klorovim atomom ali z metilom, metoksi, nitro ali amino, ali je v primeru benzenskega obroča le-ta lahko mono-, di- ali trisubstituiran s 2 fluorovimi ali klorovimi atomi ali merilno, trifluorometilno, nitro, hidroksilno, metoksi, amino, monometil- ali dimetilamino skupino, in njegove soli s fiziološko sprejemljivimi kislinami.
2. Spojine s formulo I po zahtevku 1, označene s tem, da jih uporabimo za zdravljenje psihoz.
3. Postopek za pripravo spojin s formulo I, kot so zahtevane v zahtevku 1, ki obsega presnovo spojine s formulo II
Z' (Π) Λ kjer imajo n, R , X, Y, Z in A zgoraj navedene pomene in je Nu nukleofugna odhodna skupina, s 3-azabiciklo[3.2.0]heptanskim derivatom s formulo III
kjer ima R1 zgoraj navedene pomene, in pretvorbo nastale spojine, v danem primeru, v sol s fiziološko sprejemljivo kislino.
SI9520094A 1994-08-04 1995-07-21 N-substituirani 3-azabiciklo/3.2.0/ heptanski derivati uporabni kot nevroleptiki SI9520094B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4427648A DE4427648A1 (de) 1994-08-04 1994-08-04 N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
PCT/EP1995/002893 WO1996004272A1 (de) 1994-08-04 1995-07-21 N-substituierte 3-azabicyclo(3.2.0)heptan-derivate als neuroleptika

Publications (2)

Publication Number Publication Date
SI9520094A SI9520094A (en) 1997-08-31
SI9520094B true SI9520094B (sl) 2002-02-28

Family

ID=6524944

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9520094A SI9520094B (sl) 1994-08-04 1995-07-21 N-substituirani 3-azabiciklo/3.2.0/ heptanski derivati uporabni kot nevroleptiki

Country Status (25)

Country Link
US (1) US6028073A (sl)
EP (1) EP0775135B1 (sl)
JP (1) JPH10503503A (sl)
CN (1) CN1066145C (sl)
AT (1) ATE242236T1 (sl)
AU (1) AU696230B2 (sl)
BG (1) BG63633B1 (sl)
CA (1) CA2196809A1 (sl)
CZ (1) CZ287862B6 (sl)
DE (2) DE4427648A1 (sl)
DK (1) DK0775135T3 (sl)
ES (1) ES2201111T3 (sl)
FI (1) FI970448A (sl)
HR (1) HRP950438A2 (sl)
HU (1) HUT77772A (sl)
MX (1) MX9700807A (sl)
NO (1) NO312243B1 (sl)
NZ (1) NZ290426A (sl)
PL (1) PL183526B1 (sl)
PT (1) PT775135E (sl)
RU (1) RU2163604C2 (sl)
SI (1) SI9520094B (sl)
UA (1) UA44903C2 (sl)
WO (1) WO1996004272A1 (sl)
ZA (1) ZA956477B (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458821B1 (en) * 1998-08-12 2002-10-01 Abbott Laboratories N-substituted azabicycloheptane derivatives, production and use thereof
DE19836404A1 (de) * 1998-08-12 2000-02-17 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE19836406A1 (de) * 1998-08-12 2000-02-17 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE19848521A1 (de) * 1998-10-21 2000-04-27 Basf Ag Verfahren zur Herstellung von (+)-exo-6-Phenyl-3-azabicyclo-[3.2.0]heptanen
DE19854147A1 (de) * 1998-11-24 2000-05-25 Basf Ag Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht
JP4754570B2 (ja) * 2004-10-14 2011-08-24 アボット ゲーエムベーハー ウント カンパニー カーゲー ドーパミンd3受容体の調節に応答する障害の治療に好適なアザビシクロヘプチル化合物
US10233191B2 (en) 2013-07-10 2019-03-19 Vertex Pharmaceuticals Incorporated Fused piperidine amides as modulators of ion channels
CR20160578A (es) * 2014-06-26 2017-02-21 Hoffmann La Roche Derivados de indolin-2-ona o pirrolo-piridin-2-ona
CN108349944B (zh) 2015-11-06 2021-03-30 豪夫迈·罗氏有限公司 二氢吲哚-2-酮衍生物
WO2017076932A1 (en) 2015-11-06 2017-05-11 F. Hoffmann-La Roche Ag Indolin-2-one derivatives useful in the treatment of cns diseases
EP3371169B1 (en) 2015-11-06 2019-07-17 H. Hoffnabb-La Roche Ag Indolin-2-one derivatives for use in the treatment of cns and related disorders
CN108137561B (zh) 2015-11-06 2021-03-26 豪夫迈·罗氏有限公司 二氢吲哚-2-酮衍生物
WO2020239073A1 (zh) * 2019-05-30 2020-12-03 中国科学院上海药物研究所 一种并环化合物、其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4341402A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
MX9700807A (es) 1997-05-31
FI970448A0 (fi) 1997-02-03
FI970448A (fi) 1997-04-03
WO1996004272A1 (de) 1996-02-15
JPH10503503A (ja) 1998-03-31
CN1156454A (zh) 1997-08-06
HRP950438A2 (en) 1997-10-31
UA44903C2 (uk) 2002-03-15
RU2163604C2 (ru) 2001-02-27
NO970473L (no) 1997-04-01
NO970473D0 (no) 1997-02-03
ATE242236T1 (de) 2003-06-15
EP0775135B1 (de) 2003-06-04
PL318460A1 (en) 1997-06-09
PL183526B1 (pl) 2002-06-28
ZA956477B (en) 1997-02-03
CN1066145C (zh) 2001-05-23
NZ290426A (en) 1998-02-26
NO312243B1 (no) 2002-04-15
US6028073A (en) 2000-02-22
AU3116295A (en) 1996-03-04
DE59510713D1 (de) 2003-07-10
BG63633B1 (bg) 2002-07-31
PT775135E (pt) 2003-10-31
CZ287862B6 (en) 2001-02-14
BG101220A (en) 1997-08-29
CZ31097A3 (en) 1997-10-15
ES2201111T3 (es) 2004-03-16
SI9520094A (en) 1997-08-31
EP0775135A1 (de) 1997-05-28
CA2196809A1 (en) 1996-02-15
AU696230B2 (en) 1998-09-03
DE4427648A1 (de) 1996-02-08
HUT77772A (hu) 1998-08-28
DK0775135T3 (da) 2003-09-29

Similar Documents

Publication Publication Date Title
SI9520094B (sl) N-substituirani 3-azabiciklo/3.2.0/ heptanski derivati uporabni kot nevroleptiki
UA42869C2 (uk) Похідні саліцилової кислоти, спосіб одержання, фармацевтична композиція для лікування аутоімунного захворювання та спосіб лікування
DE69513383T2 (de) Substituierte 3-arylidinene-7-azaoxindol verbindungen und verfahren zu ihrer herstellung
CA2296031A1 (en) Novel spiroazabicyclic heterocyclic compounds
HUP9904703A2 (hu) Aminotiofén-karbonsav-amidok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
ZA914148B (en) Tinctorial composition based on 5,6-dihydroxyindolines and method for dyeing keratinous fibres
DE3685248D1 (de) 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel.
NZ334548A (en) Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
ATE167862T1 (de) Benzimidazolderivate, verfahren zu deren herstellung und anwendung
ATE181731T1 (de) Isothioharnstoff-derivate als no synthase hemmer
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
ES2037665T3 (es) Procedimiento para la preparacion de compuestos heterociclicos que contienen n.
SE8900372D0 (sv) Antibakteriell munvaardskomposition
DE3861837D1 (de) Substituierte 2-nitrometaphenylendiamine, verfahren zu ihrer herstellung und ihre verwendung fuer die faerbung von keratinischen fasern, insbesondere von menschlichen haaren.
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ES523425A0 (es) Un metodo para preparar nuevos derivados de guanina
EA200100825A1 (ru) Новые 1-арил-4-тиотриазины
ES2067882T3 (es) Procedimiento de preparacion de la 1-(2,3,4-trimetoxi-bencil)-piperacina mediante aminacion reductiva.
PT71658A (en) Process for the preparation of an aqueous acidic lubricantcoating composition applied in the treatment of metal surfaces
ATE157982T1 (de) Hydroxyalkanphosphonsäuren, deren derivate und diese enthaltende schmiermittel
YU45758B (sh) Postopek za pripravo 12-amino-piridizino /4'5':3,4/-pirolo/2,1-a/ izokinolinov
HUP9900642A2 (hu) Símaizom sejtburjánzást gátló 2-szubsztituált benzimidazolszármazékok, eljárás előállításukra és alkalmazásuk gyógyszerkészítmények előállítására
ZA8346B (en) Diazolylalkanols,process for their prepartion and their use as antimycotic agents
PT82175A (de) Neue 3-pyridylmethylnaphthylderivate verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3460733D1 (en) N-(3-trifluoromethyl phenyl)-n'-propargyl piperazine, method for its preparation and its use